Luye Pharma Group Ltd.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.01 EUR
63.60 M EUR
816.91 M EUR
2.14 B
About Luye Pharma Group Ltd.
Sector
Industry
CEO
Dian Bo Liu
Website
Headquarters
Guangzhou
Founded
1994
IPO date
Jul 9, 2014
Identifiers
3
ISIN BMG570071099
Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling of pharmaceutical products. It operates through the following segments: Oncology Drugs, Cardiovascular System Drugs, Alimentary Tract and Metabolism Drugs, Central Nervous System Drugs, and Others. The company was founded on June 8, 1994 and is headquartered in Yantai, China.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
513120
GF CSI Hong Kong Brand Name Drug Exchange Traded Fund UnitsWeight
1.08%
Market value
20.52 M
USD
159892
ChinaAMC Hang Seng Hong Kong-Listed Biotech Index ETF Units AWeight
0.87%
Market value
5.55 M
USD
159567
Yinhua China Sec Hong Kong Stock Connect Innovative Drug EtfWeight
0.78%
Market value
3.23 M
USD
513200
E Fund CSI HK Connect Health Care Composite Exchange Traded Fund UnitsWeight
0.82%
Market value
2.58 M
USD
513780
INVESCO Great Wall CSI Hong Kong Connect Innovative Drug Exchange Traded Fund UnitsWeight
1.10%
Market value
1.69 M
USD
520700
Wanjia CSI Hong Kong Connect Innovative Drug Exchange Traded Fund UnitsWeight
1.06%
Market value
756.98 K
USD
Explore more ETFs
Frequently Asked Questions
The current price of LUP is 0.29 EUR — it hasn't changed in the past 24 hours. Watch Luye Pharma Group Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Luye Pharma Group Ltd. stocks are traded under the ticker LUP.
LUP stock has fallen by −5.96% compared to the previous week, the month change is a −3.40% fall, over the last year Luye Pharma Group Ltd. has showed a 15.08% increase.
LUP stock is 2.07% volatile and has beta coefficient of 1.06. Track Luye Pharma Group Ltd. stock price on the chart and check out the list of the most volatile stocks — is Luye Pharma Group Ltd. there?
Today Luye Pharma Group Ltd. has the market capitalization of 1.17 B, it has decreased by −4.32% over the last week.
Yes, you can track Luye Pharma Group Ltd. financials in yearly and quarterly reports right on TradingView.
Luye Pharma Group Ltd. is going to release the next earnings report on Apr 1, 2026. Keep track of upcoming events with our Earnings Calendar.
LUP earnings for the last half-year are 0.01 EUR per share, whereas the estimation was 0.01 EUR, resulting in a 18.86% surprise. The estimated earnings for the next half-year are 0.01 EUR per share. See more details about Luye Pharma Group Ltd. earnings.
Luye Pharma Group Ltd. revenue for the last half-year amounts to 376.85 M EUR, despite the estimated figure of 357.81 M EUR. In the next half-year revenue is expected to reach 409.58 M EUR.
LUP net income for the last half-year is 36.33 M EUR, while the previous report showed 11.33 M EUR of net income which accounts for 220.58% change. Track more Luye Pharma Group Ltd. financial stats to get the full picture.
Luye Pharma Group Ltd. dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 4, 2026, the company has 5.15 K employees. See our rating of the largest employees — is Luye Pharma Group Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Luye Pharma Group Ltd. EBITDA is 230.69 M EUR, and current EBITDA margin is 32.07%. See more stats in Luye Pharma Group Ltd. financial statements.
Like other stocks, LUP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Luye Pharma Group Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Luye Pharma Group Ltd. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Luye Pharma Group Ltd. stock shows the sell signal. See more of Luye Pharma Group Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.